JP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice TargetHot
JP Morgan analyst Chris Schott maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $28 to $30.
JP Morgan analyst Chris Schott maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $28 to $30.